[EN] FUSED PYRIMIDINE COMPOUNDS AS KCC2 MODULATORS<br/>[FR] COMPOSÉS DE PYRIMIDINE FUSIONNÉS EN TANT QUE KCC2
申请人:ASTRAZENECA AB
公开号:WO2021180952A9
公开(公告)日:2021-12-16
[EN] FUSED PYRIMIDINE COMPOUNDS AS KCC2<br/>[FR] COMPOSÉS DE PYRIMIDINE FUSIONNÉS EN TANT QUE KCC2
申请人:ASTRAZENECA AB
公开号:WO2021180952A1
公开(公告)日:2021-09-16
The invention concerns compounds of Formula (I): (I) or pharmaceutically acceptable salts thereof, wherein R1, R2, R7 and ring A have any of the meanings hereinbefore defined in the description; process for their preparation; pharmaceutical compositions containing them and their use in treating KCC2 mediated diseases.